Table 2.
Characteristics at start pregnancy | Obstetrics | Treatment in pregnancy | Events during pregnancy | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Maternal age | Clinically recognised ARVD/C | High-risk pregnancy | GP* | Result | Duration | Delivery | Obstetric complications | Child's age at last follow-up | Medication | ICD | Increase symptoms | VA | HF onset |
1 | 27 | Yes | VA+RV structure | G1P0 | Live birth | 35 weeks | Vaginal | No | 2 years | B, dose *2 | Yes | Palpitations/PVCs | No | No |
30 | Yes | G2P1 | Miscarriage | <13 weeks | ||||||||||
30 | Yes | VA+RV structure | G3P1 | Live birth | Full term | Vaginal | No | 2 months | B, add flecainide in second trimester | Yes | Palpitations/PVCs | No | No | |
2 | 30 | Yes | No | G2P1 | Live birth | Full term | Vaginal | No | 10 years | None | Yes | Fatigue, palpitations | No | No |
40 | Yes | No | G3P2 | Live birth | Full term | Vaginal | No | 12 months | Start B in 23rd week | Yes | PVCs/NSVTs | No | No | |
3 | 37 | Yes | VA+RV structure | G1P0 | Live birth | Full term | Vaginal | Dysmaturity | 2 years | B+ diuretics when needed | Yes | Dyspnoea, palpitations | No | Yes |
4 | 32 | Yes | VA | G1P0 | Live birth | Full term | C-section | No | 4 years | Sotalol | No | No | No | No |
33 | Yes | VA | G2P1 | Live birth | Full term | C-section | No | 2 years | Sotalol | Yes | No | No | No | |
36 | Yes | G3P2 | Miscarriage | <13 weeks | ||||||||||
5 | 29 | Yes | No | G1P0 | Live birth | 34 weeks | C-section | Preterm contractions | 1 month | Sotalol+diuretics≤7 days | Yes | Mild dyspnoea | No | No |
6 | 28 | Yes | RV structure | G1P0 | Live birth | Full term | Vaginal | Child: scalp laceration infection due to use of vacuum | 5 years | B; change atenolol to metoprolol | Yes | Palpitations | Third week: ICD discharge | No |
7 | 33 | Yes | VA+RV structure | G1P0 | Live birth | Full term | C-section | No | 9 months | B | Yes | No | No | No |
8 | 28 | Yes | VA | G1P0 | Live birth | Full term | Vaginal | No | 9 months | B | Yes | No | No | No |
9 | 29 | Yes | G1P0 | Miscarriage | <13 weeks | |||||||||
30 | Yes | No | G2P0 | Live birth | Full term | Vaginal | No | 4 years | B | Yes | No | No | No | |
31 | Yes | No | G3P1 | Live birth | Full term | Vaginal | Temporary intrauterine growth restriction | 3 years | Stop B→VA→restart B | Yes | No | 18th week: antitachycardia pacing | No | |
33 | Yes | VA | G4P2 | Live birth | Full term | Vaginal | 23 months | B | Yes | No | No | No | ||
34 | Yes | VA | G5P3 | Live birth | Full term | Vaginal | Meconium-stained amniotic fluid | 3 months | B | Yes | No | No | No | |
10 | 24 | Yes | No | G1P0 | Live birth | Full term | Vaginal | No | 6 years | None (stop B in 4th–8th week) | Yes | No | No | No |
26 | Yes | No | G2P1 | Live birth | Full term | Vaginal | Preterm contractions | 5 years | None (stop B in 4th–8th week) | Yes | No | No | No | |
28 | Yes | No | G3P2 | Live birth | Full term | Vaginal | No | 3 years | None (stop B in 4th–8th week) | Yes | No | No | No | |
11 | 31 | Yes | RV structure | G1P0 | Live birth | Full term | C-section | No | 5 years | B; stop valsartan; 22nd week: + diuretics; 32nd week: + digoxin, increase diuretics | Yes | Dyspnoea, oedema, fatigue | No | Yes |
12 | 33 | Yes | No | G3P1 | Live birth | Full term | Vaginal | No | 2 years | None | Yes | No | No | No |
13 | 30 | Yes | RV structure | G1P0 | Live birth | Full term | C-section | Child: hypoglycaemia in macrosomia | 16 years | None | Yes | No | No | No |
34 | Yes | G2P1 | Miscarriage | <13 weeks | No | No | ||||||||
35 | Yes | RV structure | G3P1 | Live birth | Full term | C-section | No | 11 years | None | Yes | No | No | No | |
14 | 25 | Yes | RV structure | G1P0 | Live birth | Full term | Vaginal | No | 3 years | None | Yes | No | No | No |
27 | Yes | G2P1 | Miscarriage | <13 weeks | No | No | ||||||||
28 | Yes | RV structure | G3P1 | Live birth | Full term | Vaginal | No | Newborn | None | Yes | No | No | No | |
15 | 32 | Yes | No | G5P2 | Live birth | Full term | Vaginal | No | 3 years | None | No | No | No | No |
16 | 34 | Yes | No | G2P1 | Live birth | Full term | Vaginal | No | 18 months | None | No | No | No | No |
17 | 32 | Yes | No | G3P2 | Live birth | Full term | Vaginal | No | 2 years | B | Yes | Palpitations/PVCs | No | No |
18 | 32 | Yes | No | G2P1 | Live birth | Full term | Vaginal | No | 4 months | None | No | No | No | No |
19 | 31 | No | No | G1P0 | Live birth | Full term | C-section | No | 9 years | None | No | No | No | No |
33 | No | No | G2P1 | Live birth | Full term | C-section | No | 7 years | Start B since VA | Yes | Palpitations | 12 weeks: VT | No | |
20 | 23 | No | No | G2P1 | Live birth | Full term | Vaginal | No | 9 years | None | No | No | No | No |
21 | 32 | No | No | G2P1 | Live birth | Full term | C-section | No | 18 months | Stop B in 4th week →VA→start sotalol | Yes | PVCs | 6th week: VT+short VF | No |
22 | 34 | No | No | G3P2 | Live birth | Full term | Vaginal | No | 6 years | None | No | No | No | No |
23 | 34 | No | No | G3P2 | Live birth | Full term | C-section | No | 6 years | None | No | No | No | No |
24 | 29 | No | No | G2P1 | Live birth | Full term | Vaginal | No | 22 years | None | No | Palpitations/PVCs | No | No |
31 | No | G3P2 | Miscarriage | <13 weeks | ||||||||||
31 | No | RV structure | G4P2 | Live birth | Full term | Vaginal | No | 19 years | None | No | Fatigue | No | No | |
25 | 31 | No | No | G1P0 | Live birth | Full term | Vaginal | No | 3 years | Start B since VA | Yes | No | 6 weeks: VT | No |
32 | Yes | No | G2P1 | Live birth | Full term | Vaginal | No | 2 years | B, dose *2 when needed | Yes | Palpitations | No | No | |
26 | 25 | No | No | G1P0 | Live birth | Full term | Vaginal | Meconium stained amniotic fluid | 5 years | None | No | No | No | No |
*Gravidity–parity: gravidity refers to the number of times a subject has been pregnant including the current pregnancy, parity to the number of times a subject has given birth to a fetus with a gestational age of 24 weeks or more.
ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; B, β blocker; C-section, caesarean section; GP, gravidity–parity; HF, heart failure ≥ Class C19; ICD, implantable cardioverter defibrillator; NSVT, non-sustained ventricular tachycardia; PVC, premature ventricular complex; RV structure, structural abnormalities of the right ventricle that met major structural 2010 Task Force Criteria16; VA, sustained ventricular arrhythmia or appropriate ICD therapy for a ventricular arrhythmia; VF, ventricular fibrillation; VT, sustained ventricular tachycardia.